GRAND HOTEL KRASNAPOLSKY, AMSTERDAM
THE NETHERLANDS
Scientific Programme

Friday 28 May 1999

Genetics and anaesthesia Chairman: G Kenny (UK) Molecular basis of anaesthetic action NP Franks (UK) Genetic models and the study of anaesthetic action VJ Simpson (USA) P450 variability and opioid metabolism DD Breimer (The Netherlands)	State of the art of neuromuscular blockade Chairman: F Servin (France) Pharmacokinetic/pharmacodynamic modelling of NMBA DM Fisher (USA) NMBA and neuromuscular disease B Plaud (France) Neuromuscular transmission in the critically ill patient KS Khünl-Brady (Austria)
Intravenous anaesthesia, memory and awareness Chairman: AR Aitkenhead (UK) The neurobiology of consciousness HAC Kamphuisen (The Netherlands) Psychological consequences of unconscious perception and awareness in anaesthesia B Bonke (The Netherlands) Strategies to prevent awareness M Struys (Belgium)	Pharmacokinetics/pharmacodynamics of intravenous sedation Chairman: J Vuyk (The Netherlands) Towards a consensus on sedation in the ICU? L Beydon (France) TCI sedation in the ICU SM Groen-Mulder (The Netherlands) Patient-controlled sedation during locoregional anaesthesia N Sutcliffe (UK)

Saturday 29 May 1999

Controlling the effect site Chairman: FHM Engbers (The Netherlands) Targeting the effect site JG Bovill (The Netherlands) Effect sites of intravenous anaesthetic agents K Morita (Japan) Physiological modelling and the effect site M Weiss (Germany)

Managed perioperative care Chairman: J Raedernce) Implications of serotonin in PONV A Borgeat (Switzerland) Transdermal fentanyl for perioperative analgesia M Zenz (Germany) Remifentanil and managed anaesthesia care JR Sneyd (UK)